Participated · Series A · Jun 2026

Wellbees offers an enterprise-focused, AI-powered employee wellbeing platform operating in more than 100 countries and supporting 38 languages. The platform covers physical, mental, emotional, social, financial, occupational, environmental, intellectual, and spiritual wellbeing through services such as expert consultations, habit tracking, wellness programs, employee engagement initiatives, analytics, and next-generation Employee Assistance Programs (EAPs). Wellbees emphasizes personalized and measurable wellbeing experiences for organizations. Following its $3.6 million Series A, the company is planning expansion across the Gulf, including opening a Qatar office and growing a regional team. Wellbees will also invest in software and product development and enhance its AI capabilities with the new funding. The company has attracted both institutional and angel participation, including existing investor Sabancı Ventures.

Participated · Seed · Jun 2026

Promake offers an AI-driven platform designed to simplify and centralize digital operations for small businesses via a conversational interface that handles website setup, domain acquisition, corporate email, e-commerce infrastructure, payment integrations and digital advertising. The company launched its services globally in February and closed a $4 million financing round to support its next growth stage. Promake plans to use the new capital to reinforce its AI backbone, grow its team, expand into new geographic markets and develop additional end-to-end service layers covering business setup and management. Leadership frames the product as a digital team member that lets users perform tasks with natural language rather than complex management panels. Coverage names Emre Tekin as CEO and lists founders Eren, Evren and Dinçer as part of the founding team. Promake cites the global opportunity of serving hundreds of millions of small businesses as a long-term market objective.

Participated · Equity · Apr 2026

PhiTech operates a clinical decision-support platform called G&M (Genomik ve Dahası) that simultaneously analyzes patients’ DNA (genomic) and RNA (transcriptomic) sequencing data to produce actionable results for hospitals, genetic diagnostic laboratories and pharmaceutical companies. The platform aims to increase diagnostic yield in complex cases where DNA-only tests are insufficient, and the company reports that many previously undiagnosed patients in Turkey reached correct diagnoses using its system in the past year. PhiTech maintains its research and development center in Turkey and has offices in the United States and the Netherlands, while pursuing international patent applications for its software. With the newly raised $2.4 million, the company plans to broaden market adoption of its rare-disease solutions and finalize research programs for cancer-directed products. Founding scientific leaders include Dr. Saliha Durmuş, Prof. Dr. Tunahan Çakır and Prof. Dr. Erdoğan Sevilgen.

Led · Equity · Dec 2025

reprai, founded in 2024 by Didem Aral and Özhan Öztürk, develops artificial-intelligence software that helps pharmaceutical firms personalize and optimize their interactions with doctors and other healthcare professionals. Its models analyze data to deliver the right message through the right channel at the right time, boosting campaign performance and return on investment while remaining fully compliant with industry regulations. The platform also supplies a measurable digital-marketing infrastructure that streamlines channel selection and budget allocation. With the latest capital, the U.S.–based startup plans to expand across the American and European markets, increase its market share, and enhance its underlying AI technology. Management emphasizes scalable growth in strategic geographies and aims to set new standards for the sector’s digital engagement. No operating metrics such as revenue or user counts were disclosed in the article.

Participated · Equity · Dec 2025

Founded in 2022 by Güven Bölükbaşı, Gökmen Güven and Mehmet Kıral, Buluttan builds AI-driven weather intelligence solutions. Its platform produces location-specific, high temporal and geographic resolution numerical forecasts and machine-learning models. The SaaS suite underpins decision-support systems for air, land and sea transportation as well as logistics operations, while also delivering production forecasts and market analytics to wind, solar and hydroelectric power plants. Buluttan is a member of the Horizon WeatherGenerator consortium, collaborating with leading European national meteorology agencies to create a foundational AI atmospheric model. To date the company has raised $2 million in equity funding. The latest capital will accelerate growth in Turkey and support expansion into European and Middle Eastern markets.